DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Sabcomeline
Sabcomeline
WITHOUTUS010307409B2 (12 ) United States Patent ( 10 ) Patent No
Wo 2007/128674 A2
Alzheimer's Disease Clinical Trials
The Profile of Sabcomeline (SB-202026), a Functionally Selective M1 Receptor Partial Agonist, in the Marmoset
30Th Annual Meeting of Society for Neuroscience. New Drugs Affecting the Central Nervous System New Orleans, Louisiana, USA November 4–9, 2000
Alzheimer Syllabus
Stembook 2018.Pdf
Clinical Trials and Late-Stage Drug Development in Alzheimer's Disease: an Appraisal from 1984 to 2014
Characterization of a CNS Penetrant, Selective M1 Muscarinic Receptor Agonist, 77-LH-28-1
A Straightforward Route to Enantiopure Pyrrolizidines And
Botulinum Toxin
Customs Tariff - Schedule
(12) United States Patent (10) Patent No.: US 8,541,596 B2 Heiser Et Al
(12) Patent Application Publication (10) Pub. No.: US 2017/0095465 A1 Elenko Et Al
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Allosteric Modulation of the Muscarinic M4 Receptor As an Approach to Treating Schizophrenia
WHO Drug Information Vol. 11, No. 3, 1997
06-152 Phrma Newmed Mentill
Top View
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
(19) United States (12) Patent Application Publication (10) Pub
Customs Tariff - Schedule
Official Journal L 175
(12) Patent Application Publication (10) Pub. No.: US 2010/0120842 A1 Barlow Et Al
Pharmaabkommen A1 E
Curriculum Vitae
Customs Tariff - Schedule Xxi - 1
1.2 Histamine Receptors
Neurogenesis Via Modulation of the Muscarinic Receptors
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Mental Illnesses
(12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
Evaluation of 11C-LSN3172176 As a Novel PET Tracer for Imaging M1
2011 Medicines in Development for Women
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Effect of Sabcomeline on Muscarinic and Dopamine Receptor Binding in Intact Mouse Brain
(12) Patent Application Publication (10) Pub. No.: US 2011/0020423 A1 Elenko Et Al
The Muscarinic M1/M4 Receptor Agonist Xanomeline Exhibits Antipsychotic-Like Activity in Cebus Apella Monkeys
PROCLAMATION 7207-^ULY 1, 1999 113 STAT. 2105 to Extend Nondiscriminatory Treatment
Schedule Clxxiii - European Union